🎉 Excited to share our cover article in Cancer Research!
We identified distinct tumor‑immune ecologies in lung cancer that predict immunotherapy response—moving beyond single biomarkers to spatial interactions. #CancerResearch#Immunotherapy#TumorMicroenvironment#Biomarkers
Read the article featured on the March 1 cover and in the Cancer Research special series: Distinct Tumor-Immune Ecologies in Patients with #LungCancer Predict Progression and Define a Clinical Biomarker of Therapy Response doi.org/10.1158/0008-5472.CA…@sandhya212@ara_anderson
The last presentation from the #AndersonLab was by Khushi Jasuja, who worked with @sandhya212, “A PINN-Based Framework for NSCLC Tumor Growth and Immunotherapy Dynamics”. She was great too! @mathonco@MoffittNews
Honored to have been invited to present our research on #NSCLC from the Integrated Mathematical Oncology department (@MoffittNews@mathonco) at 2025 @NYASciences: Frontiers in Cancer Immunotherapy! Thank you @NYASciences for organizing talks from experts in #immunotherapy.
⏳ Last chance to register!
Frontiers in Cancer Immunotherapy 2025 starts next week, June 16–17 in NYC. Join leaders in RNA tech, cell therapy, innate immunity & more as we push the boundaries of cancer care.
🔗 Register now: bit.nyas.org/3Czgye0
We had a great discussion on AI-Foundational Models for Cancer Imaging Biomarkers with Dr. Hugo Aerts for the 4th AI in IO: SITC-NCI Computational Immuno-oncology Webinar Series. The recording is now available: sitcancer.org/viewdocument/c…#CancerResearch#foundationalmodels#AI